SCHEMBL19845130

SCHEMBL19845130

CC(C)n1c2ccc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)cc2c2cc(-c3ccc4c(c3)c3cc(-c5cc(-c6ccccc6)cc(-c6ccccc6)c5)ccc3n4-c3ccccc3)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASR P41180 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ ATM Q13315 1/20 0.41
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ AVPR1A P37288 1/20 0.36
▸ NPY5R Q15761 1/20 0.35
▸ TSPO P30536 1/20 0.35
▸ BCHE P06276 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ NR4A2 P43354 2/20 0.35
▸ NR1I2 O75469 1/20 0.34
▸ EGFR P00533 1/20 0.34
▸ ADRA2A P08913 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ TBXA2R P21731 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ OPRD1 P41143 1/20 0.34
▸ PDE4D Q08499 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19845143 0.91 MEN1 (0.44) CASRKDM4EL3MBTL1ATMKMT2A
SCHEMBL12683071 0.90 ATM (0.55) CASRKDM4EL3MBTL1ATMKMT2A
SCHEMBL18584204 0.90 ATM (0.55) CASRKDM4EL3MBTL1ATMKMT2A
SCHEMBL14167805 0.89 MEN1 (0.46) CASRATMKMT2AMEN1NPY5R
SCHEMBL24667522 0.88 CASR (0.46) CASRATMKMT2AMEN1NPY5R
SCHEMBL14552740 0.87 L3MBTL1 (0.52) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL29373283 0.87 L3MBTL1 (0.52) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL11910684 0.87 CASR (0.48) CASRATMKMT2AMEN1NPY5R
SCHEMBL19845137 0.87 MEN1 (0.46) CASRKDM4EL3MBTL1ATMKMT2A
SCHEMBL19845136 0.87 MEN1 (0.46) CASRKDM4EL3MBTL1ATMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-02-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE PIEZO1, ETV6, LEF1 CASR 2150/4885KDM4E 2538/4885L3MBTL1 3274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback